JMJD6 and liver cancer: Based on the data of our study, we demonstrated that JMJD6–BRD4 complex regulated the LCSC irradiation tolerance via the HOTAIR-LSD1-ERK2 (MAPK1) axis, which provided promising targets or biomarkers for the management of radioresistance in liver cancer.